According to Medifast's latest financial reports the company's total liabilities are $0.10 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.10 B | -32.72% |
2022-12-31 | $0.16 B | -17.71% |
2021-12-31 | $0.19 B | 64.81% |
2020-12-31 | $0.11 B | 32.31% |
2019-12-31 | $89.82 M | 48.9% |
2018-12-31 | $60.32 M | 61.52% |
2017-12-31 | $37.34 M | 48.21% |
2016-12-31 | $25.2 M | -8.48% |
2015-12-31 | $27.53 M | -22.29% |
2014-12-31 | $35.43 M | 3.51% |
2013-12-31 | $34.23 M | -13.25% |
2012-12-31 | $39.46 M | 22.32% |
2011-12-31 | $32.26 M | 45.97% |
2010-12-31 | $22.1 M | 45.96% |
2009-12-31 | $15.14 M | 0.31% |
2008-12-31 | $15.09 M | 33.55% |
2007-12-31 | $11.3 M | 29.03% |
2006-12-31 | $8.76 M | 2.78% |
2005-12-31 | $8.52 M | 26.06% |
2004-12-31 | $6.76 M | -5.49% |
2003-12-31 | $7.15 M | 66.01% |
2002-12-31 | $4.31 M | 426.25% |
2001-12-31 | $0.81 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.62 B | 474.10% | ๐บ๐ธ USA |
Abeona Therapeutics
ABEO | $49.17 M | -54.65% | ๐บ๐ธ USA |
Bellerophon Therapeutics
BLPH | $1.25 M | -98.84% | ๐บ๐ธ USA |